CITADEL ADVISORS LLC

Position in XCUR — Exicure, Inc.

CIK 1423053 MIAMI, FL

Position in XCUR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,031

+$20,100 QoQ

Shares Held

14,919

+310.8% QoQ

Ownership

0.228%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. XCUR ranks #403 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,031	14,919	-17.8%	Shares	Defined	2026-08-14
2024-03-31	$10,931	18,159	-13.0%	Shares	Defined	2024-05-15
2023-09-30	$15,035	20,883	-58.5%	Shares	Defined	2023-11-14
2023-06-30	$65,963	50,354	+76.4%	Shares	Defined	2023-08-14
2022-12-31	$32,829	28,547	+181.4%	Shares	Defined	2023-02-14
2022-06-30	$21,912	10,145	-97.8%	Shares	Defined	2022-08-15
2022-03-31	$93,887	469,441	+98.1%	Shares	Defined	2022-05-16
2021-12-31	$47,866	236,965	+649.7%	Shares	Defined	2022-02-14
2021-09-30	$37,929	31,608	+15.7%	Shares	Defined	2021-11-15
2021-06-30	$40,971	27,314	-12.1%	Shares	Defined	2021-08-16
2021-03-31	$67,725	31,067	—	Shares	Defined	2021-05-21
No filing history on record for this holder in this stock.